SL
AZN icon

Salomon & Ludwin’s AstraZeneca AZN Stock Holding History

Salomon & Ludwin’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$184K Buy
1,003
+329
+49% +$61.9K 0.02% 182
2026
Q1 		$137K Buy
674
+75
+13% +$14.5K 0.01% 196
2025
Q4 		$109K Buy
599
+216
+56% +$37.9K 0.01% 227
2025
Q3 		$65.3K Buy
383
+347
+964% +$52.5K 0.01% 315
2025
Q2 		$5.12K Buy
36
+20
+125% +$2.8K ﹤0.01% 563
2025
Q1 		$2.35K Sell
16
-21
-57% -$3.04K ﹤0.01% 576
2024
Q4 		$4.85K Hold
37
– – ﹤0.01% 518
2024
Q3 		$5.76K Hold
37
– – ﹤0.01% 513
2024
Q2 		$5.77K Hold
37
– – ﹤0.01% 513
2024
Q1 		$5.01K Buy
+37
New +$4.9K ﹤0.01% 635

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Salomon & Ludwin's AZN Position: Q2 2026 in Review

Salomon & Ludwin increased its AstraZeneca (AZN) stake by 49% in Q2 2026, buying an estimated $61.9K and bringing the position to 1,003 shares worth $184K. The position accounts for 0.02% of the portfolio, ranked #182.

Salomon & Ludwin first reported a position in AZN in Q1 2024 and has held it in 10 quarters since. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Salomon & Ludwin held 1,003 shares of AstraZeneca worth $184K as of Q2 2026.
  • Salomon & Ludwin bought 329 AstraZeneca shares in Q2 2026, an estimated $61.9K.
  • AstraZeneca made up 0.02% of Salomon & Ludwin's portfolio in Q2 2026, its #182 holding.
  • Salomon & Ludwin first reported a position in AstraZeneca in Q1 2024 and has held it in 10 quarters since.
  • 1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.